Free Trial

Centene (CNC) Stock Price, News & Analysis

Centene logo
$53.64 -0.35 (-0.66%)
As of 01:05 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Centene Stock (NYSE:CNC)

Key Stats

Today's Range
$53.19
$54.04
50-Day Range
$53.44
$62.82
52-Week Range
$52.93
$80.59
Volume
1.94 million shs
Average Volume
4.92 million shs
Market Capitalization
$26.69 billion
P/E Ratio
8.00
Dividend Yield
N/A
Price Target
$77.71
Consensus Rating
Moderate Buy

Company Overview

Centene Corporation is a diversified, multibillion‐dollar healthcare enterprise that provides a wide array of government‐sponsored and commercial healthcare plans and services. The company specializes in managed care programs designed to serve underinsured and uninsured individuals, with a particular focus on Medicaid, the Children’s Health Insurance Program (CHIP), Medicare, and health insurance marketplace plans. Through its integrated delivery model, Centene aims to improve health outcomes for vulnerable populations by partnering with local and state agencies to coordinate care and address social determinants of health.

In addition to traditional managed care, Centene offers a range of specialty services, including behavioral health management, pharmacy benefits management, dental and vision care, telehealth solutions, correctional healthcare, and care management for complex conditions. These services are delivered through a network of wholly owned subsidiaries and joint ventures under brands such as Envolve and WellCare, allowing Centene to tailor its offerings to the diverse needs of members and providers. The company also leverages data analytics and care coordination technologies to improve quality metrics and control costs across the continuum of care.

Founded in 1984 as a single health plan in Milwaukee, Centene has grown organically and through strategic acquisitions to serve members in all 50 U.S. states, the District of Columbia, and Puerto Rico. The company maintains an international presence in select markets in Europe and Latin America, providing managed care solutions and health services aligned with local regulatory frameworks. Headquartered in St. Louis, Missouri, Centene employs a decentralized structure that empowers regional teams to engage with community stakeholders and tailor programs to local population needs.

Under the leadership of President and Chief Executive Officer Sarah London, who assumed the role in mid-2023, Centene continues to focus on expanding access to high-quality, cost-effective care. The company’s executive team brings extensive experience in healthcare operations, financial management, and public policy, supporting Centene’s mission to transform the health of the communities it serves.

AI Generated. May Contain Errors.

Centene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

CNC MarketRank™: 

Centene scored higher than 99% of companies evaluated by MarketBeat, and ranked 15th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Centene has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 9 buy ratings, 7 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Centene has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Centene's stock forecast and price target.
  • Earnings Growth

    Earnings for Centene are expected to grow by 7.43% in the coming year, from $6.86 to $7.37 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Centene is 8.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.88.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Centene is 8.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.28.

  • Price to Earnings Growth Ratio

    Centene has a PEG Ratio of 0.65. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Centene has a P/B Ratio of 1.03. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Centene's valuation and earnings.
  • Percentage of Shares Shorted

    1.89% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 19.05%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Centene does not currently pay a dividend.

  • Dividend Growth

    Centene does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.89% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 19.05%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Centene has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.93 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 18 news articles for Centene this week, compared to 19 articles on an average week.
  • Search Interest

    Only 14 people have searched for CNC on MarketBeat in the last 30 days. This is a decrease of -42% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Centene to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Centene insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.36% of the stock of Centene is held by insiders.

  • Percentage Held by Institutions

    93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Centene's insider trading history.
Receive CNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.

CNC Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
3 'Underdog Stocks' For The Rest Of 2025
See More Headlines

CNC Stock Analysis - Frequently Asked Questions

Centene's stock was trading at $60.58 at the beginning of 2025. Since then, CNC stock has decreased by 10.9% and is now trading at $53.9810.
View the best growth stocks for 2025 here
.

Centene Corporation (NYSE:CNC) announced its quarterly earnings data on Friday, April, 25th. The company reported $2.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.52 by $0.38. Centene's quarterly revenue was up 15.4% compared to the same quarter last year.
Read the conference call transcript
.

Centene shares split on the morning of Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly created shares were issued to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Centene subsidiaries include these companies: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and others.

Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include Humana (HUM), NVIDIA (NVDA), Meta Platforms (META), American Water Works (AWK), Salesforce (CRM), Advanced Micro Devices (AMD) and Verizon Communications (VZ).

Company Calendar

Last Earnings
4/25/2025
Today
6/30/2025
Next Earnings (Estimated)
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:CNC
Employees
60,500
Year Founded
1984

Price Target and Rating

Average Stock Price Target
$77.71
High Stock Price Target
$90.00
Low Stock Price Target
$61.00
Potential Upside/Downside
+44.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
16 Analysts

Profitability

Trailing P/E Ratio
8.04
Forward P/E Ratio
7.87
P/E Growth
0.65
Net Income
$3.31 billion
Pretax Margin
2.68%

Debt

Sales & Book Value

Annual Sales
$163.07 billion
Cash Flow
$9.89 per share
Price / Cash Flow
5.46
Book Value
$52.49 per share
Price / Book
1.03

Miscellaneous

Free Float
495,812,000
Market Cap
$26.86 billion
Optionable
Optionable
Beta
0.45

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSE:CNC) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners